The COVID-19 pandemic has not only posed a threat to physical health but has also had a significant impact on the mental well-being of individuals. The pandemic has disrupted healthcare systems and has caused many individuals to forego regular health checkups and treatments. Hypertension, a chronic medical condition, requires consistent and lifelong management to prevent serious health consequences such as stroke and heart disease. The purpose of this cross-sectional study was to investigate the influence of the COVID-19 pandemic on treatment adherence and psychological well-being in a sample of hypertensive patients.
The study recruited 300 hypertensive patients from a hospital in a city in China. The participants were required to complete a set of questionnaires that assessed their socio-demographic characteristics, treatment adherence, and psychological well-being. The treatment adherence was measured using the 8-item Morisky Medication Adherence Scale, and psychological well-being was assessed using the Chinese version of the 14-item Hospital Anxiety and Depression Scale (HADS).
The results of the study showed that the overall treatment adherence rate was 70.7%, which is lower than the optimal adherence rate of 80% or higher. The study found that there was a significant negative association between the COVID-19 pandemic and treatment adherence. Specifically, the pandemic was associated with decreased treatment adherence. The study also found that the pandemic significantly affected the psychological well-being of hypertensive patients. The mean scores for anxiety and depression were 9.32 and 6.45, respectively, indicating that many patients experienced symptoms of anxiety and depression. The study found that anxiety was significantly associated with decreased treatment adherence.
The findings of this study are consistent with previous research that has found that the COVID-19 pandemic has had a negative impact on treatment adherence and psychological well-being. The study has several implications for healthcare providers and policymakers. Firstly, healthcare providers should take steps to ensure that hypertensive patients continue to receive adequate care and treatment during the pandemic. This may involve developing innovative methods of delivering care such as telemedicine, which has been shown to be effective in managing hypertension.
Secondly, healthcare providers should also be aware of the impact of the pandemic on the psychological well-being of hypertensive patients. They should consider screening patients for symptoms of anxiety and depression and providing appropriate interventions such as counseling and psychotherapy. This can not only improve the psychological well-being of patients but can also improve their treatment adherence and overall health outcomes.
Thirdly, policymakers should also consider the impact of the pandemic on the healthcare system and take steps to ensure that essential services such as hypertension management are not disrupted. This may involve increasing resources and funding for healthcare systems and developing policies that support care delivery during the pandemic.
In conclusion, the COVID-19 pandemic has had a significant impact on treatment adherence and psychological well-being in hypertensive patients. The study has highlighted the need for healthcare providers and policymakers to take steps to ensure that patients receive adequate care and treatment during the pandemic. This can not only improve the health outcomes of hypertensive patients but can also have broader implications for the healthcare system as a whole.
You must be logged in to post a comment.